Q/C Technologies, Inc.
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rh… Read more
Q/C Technologies, Inc. (QCLS) - Total Liabilities
Latest total liabilities as of September 2025: $15.91 Million USD
Based on the latest financial reports, Q/C Technologies, Inc. (QCLS) has total liabilities worth $15.91 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Q/C Technologies, Inc. - Total Liabilities Trend (2020–2024)
This chart illustrates how Q/C Technologies, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Q/C Technologies, Inc. Competitors by Total Liabilities
The table below lists competitors of Q/C Technologies, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First America Resources Corporation
PINK:FSTJ
|
USA | $7.52 Million |
|
INTL. CONS. AIR GRP - Dusseldorf Stock Exchang
DU:INR
|
Germany | €37.69 Billion |
|
UBISOFT ENTERTAIN. - Dusseldorf Stock Exchang
DU:UEN
|
Germany | €3.24 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Q/C Technologies, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Q/C Technologies, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Q/C Technologies, Inc. (2020–2024)
The table below shows the annual total liabilities of Q/C Technologies, Inc. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $6.70 Million | +31.69% |
| 2023-12-31 | $5.09 Million | +78.87% |
| 2022-12-31 | $2.84 Million | +144.04% |
| 2021-12-31 | $1.17 Million | -80.35% |
| 2020-12-31 | $5.93 Million | -- |